| Sequence Name |
Description |
Length |
Blast Hits |
min E-value |
Similarity |
GO hits |
GO names |
Enzyme Codes |
InterPro Scan |
| contig01901 |
---NA--- |
251 |
0 |
|
|
0 |
|
|
|
| contig01902 |
aldo-keto reductase family member a2 |
813 |
20 |
6.30E-85 |
87.40% |
6 |
P:carbohydrate metabolic process; C:Golgi apparatus; F:electron carrier activity; C:mitochondrion; P:cellular aldehyde metabolic process; F:aldehyde reductase activity |
EC:1.1.1.21 |
|
| contig01903 |
---NA--- |
249 |
0 |
|
|
0 |
|
|
|
| contig01904 |
family with sequence similarity member c |
760 |
20 |
9.32E-24 |
76.95% |
3 |
P:negative regulation of signal transduction; C:extracellular region; C:signal recognition particle, endoplasmic reticulum targeting |
EC:3.6.5.4 |
|
| contig01905 |
---NA--- |
857 |
0 |
|
|
0 |
|
|
|
| contig01906 |
---NA--- |
372 |
0 |
|
|
0 |
|
|
|
| contig01907 |
---NA--- |
306 |
0 |
|
|
0 |
|
|
|
| contig01908 |
vacuolar atp synthase 16 kda proteolipid subunit |
498 |
20 |
8.62E-57 |
98.10% |
9 |
F:hydrogen ion transporting ATP synthase activity, rotational mechanism; P:ATP synthesis coupled proton transport; F:metal ion binding; C:vacuolar membrane; F:ATP binding; C:membrane attack complex; F:protein binding; F:proton-transporting ATPase activity, rotational mechanism; C:proton-transporting two-sector ATPase complex |
EC:3.6.3.14 |
|
| contig01909 |
maf1 homolog ( cerevisiae) |
285 |
20 |
2.44E-32 |
97.40% |
4 |
F:transcription regulator activity; P:negative regulation of transcription from RNA polymerase III promoter; P:transcription antitermination; C:nucleus |
|
|
| contig01910 |
zinc metallopeptidase (ste24 cerevisiae) |
919 |
20 |
1.04E-129 |
89.55% |
8 |
C:Golgi membrane; C:endoplasmic reticulum membrane; P:nuclear envelope organization; F:metalloexopeptidase activity; F:metalloendopeptidase activity; P:prenylated protein catabolic process; C:integral to membrane; F:zinc ion binding |
EC:3.4.24.0 |
|
| contig01911 |
---NA--- |
260 |
0 |
|
|
0 |
|
|
|
| contig01912 |
---NA--- |
416 |
0 |
|
|
0 |
|
|
|
| contig01913 |
---NA--- |
331 |
0 |
|
|
0 |
|
|
|
| contig01914 |
h+ lysosomal v1 subunit a |
447 |
20 |
3.25E-45 |
97.05% |
11 |
P:cellular sodium ion homeostasis; F:hydrogen ion transporting ATP synthase activity, rotational mechanism; C:mitochondrion; P:response to salt stress; P:ATP synthesis coupled proton transport; F:metal ion binding; P:response to acidity; P:cellular calcium ion homeostasis; F:ATP binding; F:proton-transporting ATPase activity, rotational mechanism; C:proton-transporting two-sector ATPase complex |
EC:3.6.3.14 |
|
| contig01915 |
---NA--- |
271 |
0 |
|
|
0 |
|
|
|
| contig01916 |
phosphoglucomutase 1 |
851 |
20 |
3.33E-39 |
91.95% |
4 |
C:cytoplasm; P:cellular calcium ion homeostasis; P:glucose metabolic process; F:phosphoglucomutase activity |
EC:5.4.2.2 |
|
| contig01917 |
acyl- synthetase long-chain family member 4 |
433 |
20 |
1.03E-43 |
85.45% |
8 |
C:microsome; C:peroxisome; P:regulation of fatty acid metabolic process; F:long-chain-fatty-acid-CoA ligase activity; F:magnesium ion binding; C:integral to membrane; C:endoplasmic reticulum; C:mitochondrion |
EC:6.2.1.3 |
|
| contig01918 |
ubiquitin specific protease 4 |
636 |
20 |
8.71E-29 |
78.35% |
3 |
P:ubiquitin-dependent protein catabolic process; F:ubiquitin thiolesterase activity; C:nucleus |
EC:3.1.2.15 |
|
| contig01919 |
si:dkey- protein |
358 |
7 |
6.94E-48 |
76.71% |
2 |
F:F; C:C |
|
|
| contig01920 |
---NA--- |
253 |
0 |
|
|
0 |
|
|
|
| contig01921 |
---NA--- |
278 |
0 |
|
|
0 |
|
|
|
| contig01922 |
oxidation resistance 1 |
549 |
20 |
2.71E-29 |
85.45% |
4 |
C:nucleolus; P:response to oxidative stress; P:cell wall macromolecule catabolic process; C:mitochondrion |
|
|
| contig01923 |
mitochondrial ribosomal protein l33 |
269 |
20 |
4.40E-26 |
84.30% |
4 |
C:ribosome; F:structural constituent of ribosome; P:translation; C:mitochondrion |
EC:3.6.5.3 |
|
| contig01924 |
mitochondrial aldehyde dehydrogenase 2 |
538 |
11 |
3.66E-04 |
93.36% |
5 |
C:mitochondrion; F:oxidoreductase activity; C:mitochondrial matrix; P:metabolic process; F:aldehyde dehydrogenase (NAD) activity |
|
|
| contig01925 |
cell division cycle protein 27 homolog |
600 |
20 |
2.29E-17 |
96.30% |
7 |
P:cell proliferation; F:protein binding; C:centrosome; C:nucleus; P:mitotic metaphase/anaphase transition; C:spindle microtubule; P:cell division |
|
|
| contig01926 |
phosphoribosyl pyrophosphate amidotransferase |
977 |
20 |
1.13E-177 |
91.15% |
8 |
P:purine nucleotide biosynthetic process; P:glutamine metabolic process; P:purine base biosynthetic process; F:iron ion binding; F:amidophosphoribosyltransferase activity; F:magnesium ion binding; P:nucleoside metabolic process; F:4 iron, 4 sulfur cluster binding |
EC:2.4.2.14 |
|
| contig01927 |
na+ k+ alpha 1 polypeptide |
501 |
20 |
7.04E-30 |
99.00% |
23 |
P:otolith development; P:sodium ion transport; F:sodium:potassium-exchanging ATPase activity; P:sperm motility; F:potassium ion binding; P:brain development; P:potassium ion transport; F:monovalent inorganic cation transmembrane transporter activity; F:potassium channel inhibitor activity; F:ATP binding; P:embryonic heart tube development; C:membrane attack complex; F:magnesium ion binding; P:metabolic process; P:determination of left/right symmetry; P:regulation of cellular pH; P:embryonic body morphogenesis; P:cardiac cell differentiation; P:otic vesicle formation; P:midbrain-hindbrain boundary development; F:sodium ion binding; C:integral to plasma membrane; F:potassium channel activity |
EC:3.6.3.9 |
|
| contig01928 |
conserved domain |
265 |
20 |
2.67E-31 |
67.45% |
0 |
|
|
|
| contig01929 |
nudix-type motif 8 |
1333 |
20 |
2.06E-56 |
69.00% |
2 |
F:metal ion binding; C:mitochondrion |
|
|
| contig01930 |
cellular nucleic acid-binding protein |
1472 |
20 |
3.61E-81 |
81.90% |
10 |
C:cytosol; F:RNA binding; P:positive regulation of transcription from RNA polymerase II promoter; F:metal ion binding; F:transcription factor activity; F:single-stranded DNA binding; P:positive regulation of cell proliferation; P:cholesterol biosynthetic process; C:endoplasmic reticulum; C:nucleus |
|
|
| contig01931 |
novel protein vertebrate wee1 homolog ( pombe) |
633 |
10 |
5.01E-53 |
71.60% |
2 |
F:protein kinase activity; F:nucleotide binding |
|
|
| contig01932 |
exportin 6 |
358 |
20 |
1.60E-36 |
87.85% |
6 |
C:cytoplasm; C:nuclear pore; P:protein import into nucleus, docking; F:protein binding; F:protein transporter activity; P:protein export from nucleus |
|
|
| contig01933 |
fatty acyl reductase 1 |
570 |
20 |
4.15E-39 |
88.35% |
5 |
F:binding; F:long-chain-fatty-acyl-CoA reductase activity; P:wax biosynthetic process; C:peroxisomal membrane; C:integral to membrane |
EC:1.2.1.50 |
|
| contig01934 |
nucleoporin 85 |
2016 |
20 |
0 |
82.75% |
8 |
C:nuclear pore; F:CCR2 chemokine receptor binding; P:macrophage chemotaxis; P:lamellipodium assembly; P:intracellular protein transmembrane transport; P:cytokine-mediated signaling pathway; C:plasma membrane; P:mRNA transport |
|
|
| contig01935 |
s-adenosylhomocysteine hydrolase |
887 |
20 |
7.97E-19 |
87.50% |
14 |
C:cytosol; F:NAD or NADH binding; F:copper ion binding; F:adenyl nucleotide binding; P:circadian sleep/wake cycle; P:chronic inflammatory response to antigenic stimulus; P:response to nutrient; P:S-adenosylhomocysteine catabolic process; F:identical protein binding; F:adenosylhomocysteinase activity; F:protein self-association; P:one-carbon metabolic process; C:synaptosome; C:nucleus |
EC:3.3.1.1 |
|
| contig01936 |
nadh dehydrogenase 1 alpha subcomplex subunit 13 |
676 |
20 |
1.92E-56 |
90.30% |
13 |
P:transport; P:negative regulation of translation; P:oxygen and reactive oxygen species metabolic process; F:NADH dehydrogenase (ubiquinone) activity; C:mitochondrial respiratory chain complex I; C:integral to membrane; P:negative regulation of cell growth; P:apoptotic nuclear change; F:protein binding; P:induction of apoptosis by extracellular signals; C:nucleoplasm; P:negative regulation of transcription, DNA-dependent; P:electron transport |
EC:1.6.5.3 |
|
| contig01937 |
growth arrest and dna-damage- gamma interacting protein 1 |
642 |
20 |
5.40E-34 |
76.30% |
1 |
F:protein binding |
|
|
| contig01938 |
h+ lysosomal accessory protein 2 |
1178 |
20 |
6.57E-48 |
88.25% |
7 |
P:positive regulation of transforming growth factor-beta1 production; F:receptor activity; F:protein binding; C:external side of plasma membrane; C:integral to membrane; P:angiotensin maturation; P:regulation of MAPKKK cascade |
|
|
| contig01939 |
unnamed protein product [Tetraodon nigroviridis] |
288 |
1 |
4.25E-28 |
83.00% |
0 |
|
|
|
| contig01940 |
---NA--- |
255 |
0 |
|
|
0 |
|
|
|
| contig01941 |
---NA--- |
242 |
0 |
|
|
0 |
|
|
|
| contig01942 |
phosphoserine aminotransferase 1 |
950 |
20 |
1.33E-135 |
88.90% |
4 |
F:pyridoxal phosphate binding; F:O-phospho-L-serine:2-oxoglutarate aminotransferase activity; P:L-serine biosynthetic process; P:pyridoxine biosynthetic process |
EC:2.6.1.52 |
|
| contig01943 |
---NA--- |
658 |
0 |
|
|
0 |
|
|
|
| contig01944 |
---NA--- |
361 |
0 |
|
|
0 |
|
|
|
| contig01945 |
transcription termination rna polymerase i |
285 |
19 |
1.39E-11 |
64.16% |
12 |
F:chromatin binding; P:chromatin remodeling; P:positive regulation of transcription from RNA polymerase II promoter; C:nucleus; F:DNA binding; P:transcription initiation from RNA polymerase I promoter; P:regulation of transcription, DNA-dependent; F:RNA polymerase I transcription termination factor activity; P:negative regulation of DNA replication; P:transcription termination; F:protein binding; P:transcription |
|
|
| contig01946 |
wu:fd60e07 protein |
834 |
3 |
1.67E-11 |
67.00% |
0 |
|
|
|
| contig01947 |
---NA--- |
1138 |
0 |
|
|
0 |
|
|
|
| contig01948 |
60s acidic ribosomal protein p2 |
443 |
20 |
3.09E-19 |
83.10% |
4 |
F:structural constituent of ribosome; F:RNA binding; C:cytosolic large ribosomal subunit; P:translational elongation |
|
|
| contig01949 |
---NA--- |
360 |
0 |
|
|
0 |
|
|
|
| contig01950 |
rio kinase 2 |
595 |
20 |
4.16E-40 |
92.25% |
3 |
P:protein amino acid phosphorylation; F:ATP binding; F:protein serine/threonine kinase activity |
EC:2.7.11.0 |
|
| contig01951 |
tp53 regulated inhibitor of apoptosis 1 |
308 |
20 |
3.32E-34 |
89.20% |
5 |
F:protein binding; F:caspase inhibitor activity; P:anti-apoptosis; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; C:mitochondrion |
|
|
| contig01952 |
---NA--- |
723 |
0 |
|
|
0 |
|
|
|
| contig01953 |
mitogen-activated protein kinase kinase 4 |
608 |
20 |
2.87E-105 |
96.25% |
6 |
P:protein amino acid phosphorylation; F:protein binding; P:JNK cascade; F:ATP binding; F:protein tyrosine kinase activity; F:protein serine/threonine kinase activity |
EC:2.7.10.0; EC:2.7.11.0 |
|
| contig01954 |
---NA--- |
247 |
0 |
|
|
0 |
|
|
|
| contig01955 |
eukaryotic translation initiation factor subunit 5 47kda |
930 |
20 |
3.54E-141 |
89.40% |
4 |
C:eukaryotic translation initiation factor 3 complex; F:protein binding; P:regulation of translational initiation; F:translation initiation factor activity |
|
|
| contig01956 |
trna splicing endonuclease 2 homolog ( cerevisiae) |
772 |
20 |
4.00E-62 |
80.70% |
5 |
F:DNA binding; P:tRNA splicing, via endonucleolytic cleavage and ligation; P:mRNA processing; C:tRNA-intron endonuclease complex; F:tRNA-intron endonuclease activity |
EC:3.1.27.9 |
|
| contig01957 |
---NA--- |
934 |
0 |
|
|
0 |
|
|
|
| contig01958 |
---NA--- |
762 |
0 |
|
|
0 |
|
|
|
| contig01959 |
mitogen-activated protein kinase kinase kinase 7 interacting protein 3 |
293 |
20 |
1.93E-21 |
81.95% |
3 |
F:kinase activity; F:zinc ion binding; C:intracellular |
|
|
| contig01960 |
mitogen-activated protein kinase kinase kinase 7 interacting protein 3 |
401 |
20 |
1.41E-56 |
61.55% |
1 |
F:metal ion binding |
|
|
| contig01961 |
lyr motif-containing protein 1 |
205 |
1 |
8.04E-04 |
76.00% |
0 |
|
|
|
| contig01962 |
---NA--- |
200 |
0 |
|
|
0 |
|
|
|
| contig01963 |
---NA--- |
324 |
0 |
|
|
0 |
|
|
|
| contig01964 |
chaperonin containing subunit 6a (zeta 1) |
629 |
20 |
1.27E-93 |
95.30% |
4 |
P:protein folding; C:cytoplasm; F:unfolded protein binding; F:ATP binding |
|
|
| contig01965 |
chromosome 3 open reading frame 37 |
1323 |
20 |
6.64E-132 |
70.00% |
2 |
F:F; P:P |
|
|
| contig01966 |
yip1 domain member 6 |
1180 |
20 |
6.73E-93 |
87.15% |
2 |
C:membrane attack complex; C:endoplasmic reticulum |
|
|
| contig01967 |
atp-binding sub-family g member 2 |
1334 |
20 |
1.30E-151 |
76.85% |
6 |
P:response to drug; F:xenobiotic-transporting ATPase activity; P:transport; F:ATP binding; C:integral to membrane; F:protein homodimerization activity |
EC:3.6.3.44 |
|
| contig01968 |
eukaryotic translation initiation factor 4e |
1045 |
20 |
1.88E-64 |
92.40% |
7 |
C:cytoplasm; F:RNA 7-methylguanosine cap binding; P:translational initiation; F:protein binding; F:translation initiation factor activity; P:regulation of translation; C:nucleus |
|
|
| contig01969 |
spindle and kt associated 1 |
507 |
20 |
7.97E-13 |
87.00% |
3 |
P:mitosis; C:spindle; P:cell division |
|
|
| contig01970 |
---NA--- |
433 |
0 |
|
|
0 |
|
|
|
| contig01971 |
sphingomyelin phosphodiesterase isoform cra_a |
953 |
20 |
7.19E-97 |
69.00% |
7 |
C:integral to membrane; P:sphingomyelin catabolic process; F:sphingomyelin phosphodiesterase activity; P:peptide hormone secretion; P:signal transduction; P:response to stress; C:Golgi cis cisterna |
EC:3.1.4.12 |
|
| contig01972 |
psmd1 protein |
359 |
20 |
2.16E-41 |
99.00% |
3 |
C:cytosol; F:binding; C:protein complex |
|
|
| contig01973 |
mkiaa1931 protein |
569 |
20 |
6.97E-39 |
87.20% |
0 |
|
|
|
| contig01974 |
mitogen-activated protein-binding protein-interacting protein |
684 |
20 |
1.54E-16 |
99.25% |
5 |
P:activation of MAPKK activity; F:protein binding; C:membrane attack complex; C:late endosome membrane; C:lysosomal membrane |
|
|
| contig01975 |
---NA--- |
263 |
0 |
|
|
0 |
|
|
|
| contig01976 |
---NA--- |
163 |
0 |
|
|
0 |
|
|
|
| contig01977 |
tata box binding protein -associated rna polymerase b |
627 |
20 |
1.35E-31 |
55.90% |
4 |
P:transcription, DNA-dependent; F:transcription regulator activity; F:protein binding; C:nucleus |
|
|
| contig01978 |
tfiis central domain-containing protein 1 |
717 |
20 |
1.27E-64 |
72.90% |
7 |
F:transcription elongation regulator activity; P:transcription; F:transcription regulator activity; F:protein binding; P:regulation of transcription from RNA polymerase II promoter; F:DNA binding; C:nucleus |
|
|
| contig01979 |
plasminogen activator inhibitor type member 2 isoform 3 |
732 |
20 |
7.92E-17 |
91.70% |
1 |
F:serine-type endopeptidase inhibitor activity |
|
|
| contig01980 |
phospholipase a2-activating protein |
673 |
20 |
2.81E-84 |
74.20% |
5 |
P:signal transduction; P:inflammatory response; F:phospholipase A2 activator activity; P:phospholipid metabolic process; F:protein binding |
|
|
| contig01981 |
m-phase phosphoprotein 6 |
441 |
20 |
2.96E-46 |
83.35% |
5 |
C:cytoplasm; C:nucleus; P:regulation of cell cycle; F:protein binding; P:M phase of mitotic cell cycle |
|
|
| contig01982 |
pumilio 1 |
278 |
20 |
2.16E-17 |
93.50% |
2 |
F:RNA binding; P:regulation of translation |
|
|
| contig01983 |
non-protein coding rna 153 |
845 |
4 |
2.51E-47 |
49.00% |
2 |
P:P; C:C |
|
|
| contig01984 |
adp-ribosylation-like factor 6 interacting protein 4 |
307 |
1 |
3.24E-05 |
76.00% |
2 |
F:F; C:C |
|
|
| contig01985 |
low density lipoprotein receptor adaptor protein 1 |
737 |
20 |
3.09E-42 |
64.95% |
14 |
C:cytosol; P:regulation of protein binding; C:basal plasma membrane; P:positive regulation of receptor-mediated endocytosis; F:protein C-terminus binding; F:phosphotyrosine binding; F:clathrin binding; C:early endosome; C:AP-2 adaptor complex; F:receptor signaling complex scaffold activity; P:cholesterol homeostasis; P:steroid metabolic process; ; C:AP-1 adaptor complex |
|
|
| contig01986 |
---NA--- |
279 |
0 |
|
|
0 |
|
|
|
| contig01987 |
---NA--- |
694 |
0 |
|
|
0 |
|
|
|
| contig01988 |
phosphohistidine phosphatase 1 |
304 |
20 |
3.25E-13 |
84.25% |
5 |
C:cytoplasm; F:hydrolase activity; P:P; C:C; F:phosphoprotein phosphatase activity |
|
|
| contig01989 |
glutamate-cysteine catalytic subunit |
764 |
20 |
1.00E-33 |
85.40% |
26 |
P:response to arsenic; ; P:regulation of mitochondrial depolarization; P:response to nitrosative stress; P:response to xenobiotic stimulus; P:L-ascorbic acid metabolic process; F:ADP binding; C:cytosol; F:protein heterodimerization activity; P:anti-apoptosis; P:negative regulation of neuron apoptosis; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:cysteine metabolic process; F:glutamate binding; F:coenzyme binding; F:magnesium ion binding; C:glutamate-cysteine ligase complex; P:response to heat; P:negative regulation of transcription; P:glutamate metabolic process; P:negative regulation of protein ubiquitination; P:glutathione biosynthetic process; P:response to hormone stimulus; P:regulation of blood vessel size; P:response to oxidative stress; F:glutamate-cysteine ligase activity |
EC:6.3.2.2 |
|
| contig01990 |
deaminase domain containing 1 |
402 |
20 |
2.27E-14 |
88.80% |
4 |
F:hydrolase activity; P:zinc ion transport; F:zinc ion binding; P:tRNA processing |
|
|
| contig01991 |
wd repeat domain 4 |
397 |
20 |
1.01E-54 |
77.80% |
2 |
C:extracellular space; C:nucleoplasm |
|
|
| contig01992 |
---NA--- |
415 |
0 |
|
|
0 |
|
|
|
| contig01993 |
zinc finger protein 294 |
243 |
20 |
6.26E-41 |
97.25% |
2 |
F:zinc ion binding; F:protein binding |
|
|
| contig01994 |
uncharacterized conserved protein |
593 |
20 |
5.56E-29 |
57.70% |
2 |
C:mitochondrion; F:F |
|
|
| contig01995 |
coenzyme q10 homolog a |
638 |
20 |
5.44E-39 |
79.95% |
1 |
C:mitochondrion |
|
|
| contig01996 |
isoleucyl-trna synthetase |
476 |
20 |
1.65E-41 |
94.05% |
5 |
C:cytoplasm; C:soluble fraction; P:isoleucyl-tRNA aminoacylation; F:ATP binding; F:isoleucine-tRNA ligase activity |
EC:6.1.1.5 |
|
| contig01997 |
membrane-associated ring finger 7 |
1148 |
20 |
1.83E-63 |
77.90% |
1 |
F:metal ion binding |
|
|
| contig01998 |
high-mobility group 20a |
251 |
20 |
1.07E-16 |
93.75% |
5 |
P:chromatin modification; F:protein binding; F:transcription factor activity; C:nucleus; P:regulation of transcription, DNA-dependent |
|
|
| contig01999 |
splicing arginine serine-rich 5 |
1486 |
20 |
8.45E-70 |
83.55% |
7 |
P:mRNA splice site selection; C:spliceosomal complex; F:RNA binding; F:protein binding; P:regulation of cell cycle; P:regulation of transcription, DNA-dependent; F:nucleotide binding |
|
|
| contig02000 |
preimplantation protein 4 |
456 |
20 |
1.21E-60 |
80.40% |
4 |
P:glycerol metabolic process; P:carbohydrate metabolic process; F:glycerophosphodiester phosphodiesterase activity; F:carbohydrate binding |
EC:3.1.4.46 |
|
100 Rows returned.
Helpdesk 